N-(4-methylbenzyl)-3-(1-((2-(morpholinoamino)pyridin-4-yl)oxy)ethyl)benzamide

ID: ALA4170026

PubChem CID: 141482502

Max Phase: Preclinical

Molecular Formula: C26H30N4O3

Molecular Weight: 446.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(NN4CCOCC4)c3)c2)cc1

Standard InChI:  InChI=1S/C26H30N4O3/c1-19-6-8-21(9-7-19)18-28-26(31)23-5-3-4-22(16-23)20(2)33-24-10-11-27-25(17-24)29-30-12-14-32-15-13-30/h3-11,16-17,20H,12-15,18H2,1-2H3,(H,27,29)(H,28,31)

Standard InChI Key:  WSVHAALEDZEQMN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   10.8243  -22.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8232  -23.4945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5353  -23.9076    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2491  -23.4940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2463  -22.6672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5335  -22.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9616  -23.9056    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9629  -24.7269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5311  -21.4448    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2376  -21.0341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2352  -20.2169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9465  -21.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9468  -22.2551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6549  -22.6615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3623  -22.2508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3573  -21.4293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6486  -21.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0623  -21.0162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7727  -21.4201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0570  -20.1990    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.7780  -22.2373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4883  -22.6413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4908  -23.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2003  -23.8600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9064  -23.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8984  -22.6254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1883  -22.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6172  -23.8498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2493  -25.1339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2486  -25.9516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9587  -26.3650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6711  -25.9545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6735  -25.1305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 25 28  1  0
  8 29  1  0
  8 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4170026

    ---

Associated Targets(Human)

HCC78 (247 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H3122 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROS1 Tclin Proto-oncogene tyrosine-protein kinase ROS (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.55Molecular Weight (Monoisotopic): 446.2318AlogP: 4.12#Rotatable Bonds: 8
Polar Surface Area: 75.72Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 12.79CX LogP: 3.98CX LogD: 2.49
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.54Np Likeness Score: -1.37

References

1. Tian Y, Zhang T, Long L, Li Z, Wan S, Wang G, Yu Y, Hou J, Wu X, Zhang J..  (2018)  Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors.,  143  [PMID:29174814] [10.1016/j.ejmech.2017.11.002]

Source